Development of shielding device for bremsstrahlung radiation from Y-90 microspheres

Y-90 microsphere 로부터 생성되는 제동복사선의 차폐를 위한 차폐체 개발 연구

  • Park, Jun Young (Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine)
  • 박준영 (연세의료원 세브란스병원 핵의학과)
  • Received : 2019.02.28
  • Accepted : 2019.03.02
  • Published : 2019.04.27

Abstract

Purpose Yttrium-90 (Y-90) is high-energy beta emitters ($E{\beta}$, max = 2.28 MeV) with the mean penetration depth of 2.5 mm in tissue. Radioactive microspheres containing Y-90 is widely used for the transarterial radioembolization of hepatocellular carcinoma. However, bremsstrahlung radiation from Y-90 can cause the external radiation exposure to medical staff who handle the Y-90 microspheres. In this study, shielding device for Y-90 microspheres was developed to minimize the external radiation exposure. Materials and Methods Y-90 microsphere shielding device was made from 6 mm thicknesses of tungsten including the lead glass window. Radiation shielding ability of Y-90 microsphere shielding device was evaluated using 4 GBq of $SIR-Spheres^{(R)}$ Y-90 microspheres. The bremsstrahlung radiation was measured using radiation survey meter. Results The mean radiation dose of Y-90 microspheres in acrylic shield was $261.7{\pm}2.3{\mu}Sv/h$ (n=5) at 10 cm away from the shield. With the additional tungsten shielding device, it was $23.7{\pm}1.3{\mu}Sv/h$ (n=5). Thus, the bremsstrahlung radiation dose was decreased by 90.9%. At 50 cm away from the shield, bremsstrahlung radiation was reduced by 89.2% after using tungsten shielding device. Conclusion During the preparation and radioembolization of Y-90 microsphere, medical staff are exposed to external radiation. In this study, we demonstrated that the use of tungsten shielding device devices significantly reduced the amount of bremsstrahlung radiation. Y-90 microsphere tungsten shielding device can be highly effective in reducing the bremsstrahlung radiation.

본 연구는 고에너지의 베타선을 방출하는 Y-90 미세구의 경동맥방사선색전술 시 발생되는 제동복사선에 의한 불필요한 외부피폭을 줄이고자 텅스텐 차폐체를 개발하였다. 본 연구에서는 다양한 용량(1 GBq, 2 GBq, 4 GBq)의 $SIR-Spheres^{(R)}$ Y-90 미세구를 사용하여, 텅스텐 차폐체 표면으로부터 10 cm, 50 cm, 100 cm인 곳에서 GM tube식 디지털 서베이미터로 선량률을 측정하였다. 텅스텐 차폐체 표면 10 cm 위치에서 차폐율을 분석한 결과 4 GBq의 $SIR-Spheres^{(R)}$ Y-90 미세구의 경우 90.9%, 2 GBq의 경우 88.9%, 1 GBq의 경우 88.8%의 차폐율을 보였고, 표면 50 cm 위치에서 차폐율은 4 GBq의 $SIR-Spheres^{(R)}$ Y-90 미세구의 경우 89.2%, 2 GBq의 경우 87.5%, 1GBq의 경우 86.3%로 나타났다. 텅스텐 차폐체 표면 100 cm 위치에서 텅스텐 차폐체는 평균 75.1%의 차폐율을 보이는 것으로 확인할 수 있었다. 높은 용량이 함유된 $SIR-Spheres^{(R)}$ Y-90 미세구의 경동맥방사선색전술시 방사선 작업종사자와 선원간의 거리가 짧고, 작업시간이 길기 때문에 제동복사선에 의한 피폭에 노출될 수 있다. 본 연구를 통해 개발된 텅스텐 차폐체는 향후 임상에서 경동맥방사선색전술 시 제동복사선에 의한 외부피폭을 줄이는데 활용될 수 있을 것이라 기대 된다.

Keywords

References

  1. Boyle DA. Hepatocellular carcinoma: implications for asia-pacific oncology nurses. Asia Pac J Oncol Nurs. 2017;4:98-103 https://doi.org/10.4103/2347-5625.204497
  2. 통계청. 2017 사망원인통계. 온라인 간행물; 2018. p.1-55
  3. Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018 https://doi.org/10.1038/nrdp.2016.18
  4. Korean Liver Cancer Study Group. 2014 Korean liver cancer study group-national cancer center korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol. 2015; 16:465-522 https://doi.org/10.3348/kjr.2015.16.3.465
  5. 대한간암학회, 국립암센터. 2018 간세포암종 진료 가이드라인. 온라인 간행물; 2018. p.1-169
  6. 보건복지부, 신의료기술평가위원회. 동맥경유 방사선색전술의 신의료기술평가보고서. 온라인 간행물; 2010. p.1-180
  7. Bouvry C, Palard X, Edeline J, Ardisson V, Loyer P, Garin E, et al. Transarterial Radioembolization (TARE) Agents beyond $^{90}Y$-Microspheres. Biomed Res Int. 2018; 2018:1435302 https://doi.org/10.1155/2018/1435302
  8. Kassis AI. Therapeutic radionuclides: biophysical and radiobiologic principles. Semin Nucl Med. 2008; 38:358-366 https://doi.org/10.1053/j.semnuclmed.2008.05.002
  9. Chung JW. Recent advance in international management of hepatocellular carcinoma. J Korean Med Assoc. 2013;56:972-982 https://doi.org/10.5124/jkma.2013.56.11.972